Manufacturer of pharmaceuticals
Issues related to drug pricing and the Medicare Part D program; monitored issues related to the Medicare outpatient payment system. Issues related to antimicrobials; issues related to the reauthorization of PAHPA; Monitored issues related to the Right to Try Act of 2018; S. 1827; Monitored issues related to Keep Kids Insurance Dependable and Secure Act of 2017; Issues related to the Animal Drug User Fee (ADUFA) and Animal Generic Drug User Fee Act (AGDUFA). H.R 1892 The Bipartisan Budget Act of 2018 and issues related to Medicare drug pricing; H.R. 1625,  Monitored the Consolidated Appropriations Act 2018 and issues related to Medicare drug pricing.
MMM - Medicare/Medicaid HCR - Health Issues BUD - Budget/Appropriations
11 - Executive Office of the President (EOP) 135 - Food & Drug Administration (FDA) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 11 - Executive Office of the President (EOP) 135 - Food & Drug Administration (FDA) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 11 - Executive Office of the President (EOP) 135 - Food & Drug Administration (FDA) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
THE NICKLES GROUP, LLC
601 13th St. NW, Suite 250 N, Washington, DC, 20005, US
STACEY HUGHES EMILY PORTER STACEY HUGHES EMILY PORTER STEPHANIE BADGER STACEY HUGHES EMILY PORTER